InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Neil F. McFarlane
12 Oct 2026
President and CEO
Sold on a plan
20,000
$11.25
$224.95K
Rahsaan Thompson
14 Aug 2026
Chief Legal & Compliance
Sold on a plan
42,666
$11.13
$474.77K
Rahsaan Thompson
22 Jun 2026
Chief Legal & Compliance
Sold on a plan
34,557
$12.68
$438.30K
Rahsaan Thompson
11 May 2026
Chief Legal & Compliance
Sold on a plan
1,794
$11.30
$20.27K
Neil F. McFarlane
9 Feb 2026
President and CEO
Sold on a plan
14,625
$8.56
$125.19K
Joshua Schafer
3 Feb 2026
CCO
Sold on a plan
10,500
$9.19
$96.50K
Timothy J. Sangiovanni
3 Feb 2026
SVP, Finance & Corp Controller
Sold on a plan
3,000
$9.18
$27.55K
Neil F. McFarlane
2 Feb 2026
President and CEO
Sold on a plan
91,000
$9.38
$853.43K
Rahsaan Thompson
26 Jun 2025
Chief Legal & Compliance
Sold on a plan
24,000
$9.21
$221.00K
Neil F. McFarlane
14 Feb 2025
President and CEO
Sold on a plan
30,544
$8.05
$245.96K
Neil F. McFarlane
13 Feb 2025
President and CEO
Sold on a plan
61,273
$7.86
$481.43K
R. LaDuane Clifton
13 Feb 2025
CFO & Treasurer
Sold on a plan
11,000
$7.86
$86.47K
Joshua Schafer
13 Feb 2025
CCO & EVP, Bus. Development
Sold on a plan
10,500
$7.86
$82.53K
Timothy J. Sangiovanni
13 Feb 2025
SVP, Finance & Corp Controller
Sold on a plan
3,000
$7.86
$23.59K
Show all 176 transactions →

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 6
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,575,641
History held since 17 Apr 2015